ECE2013 Poster Presentations Adrenal cortex (64 abstracts)
Human leukocyte antigen (DQ2/DQ8) and 21-hydroxylase antibodies determine the thyroid peroxidase antibody status of patients in autoimmune Addison's disease
Marissa Penna-Martinez 1 , Julia M. Schwartz 1 , Faroquhi Shoghi 1 , Gesine Meyer 1 , Anette B. Wolff 2 , Stephanie Hahner 3 , Holger Willenberg 4 , Nicole Reisch 5 , Marcus Quinkler 6 , Christian Seidl 7 , Eystein Husebye 2 & Klaus Badenhoop 1
1Division of Endocrinology, Department of Internal Medicine, University Hospital, Frankfurt, Main, Germany; 2Institute of Medicine, University of Bergen, Bergen, Norway; 3Division of Endocrinology and Diabetes, Department of Internal Medicine, University Hospital Wuerzburg, Wuerzburg, Germany; 4Department of Endocrinology, Diabetes and Rheumatology, University Hospital Düsseldorf, Düsseldorf, Germany; 5Division of Endocrinology and Diabetes, Department of Internal Medicine, University Hospital Munich, Munich, Germany; 6Department of Transplantation Immunology, Red Cross Blood Donor Service, Institute of Transfusion Medicine and Immunohaematology, Frankfurt, Main, Germany; 7Clinical Endocrinology, Charite Center Campus, Berlin, Germany.
Autoimmune Addison’s disease (AAD) results from the immune mediated selective destruction of adrenal steroid hormone-secreting cells. Autoantibodies (Abs) against 21-hydroxylase (21OH) are diagnostic present in 85–90% newly diagnosed patients. Its genetic susceptibility is conferred by human leukocyte antigen (HLA) DQ2 and DQ8. In many patients autoimmunity extends forming the autoimmune polyglandular syndrome type 2 (APS-2). The aim of this study was to test, whether specific HLA alleles in combination with the 21OHAb status were associated with thyroid autoimmunity as detected by thyroid peroxidase autoantibodies (TPO-Abs) in patients with AAD.
Patients with AAD (n=194) were genotyped for HLA. and TPO-Abs were measured using an enzyme-linked immunosorbent assay, 21OH-Abs with an in vitro transcription/translation method. The titers of Abs were quantified and defined as positive (pos) or negative (neg) (21OH-Ab >48<index; TPOAb >100<UI/ml). Statistical analysis used Kruskall-Wallis and Spearman’s correlation tests.
HLA high risk (R) alleles (DQ2 and/or DQ8), 21OHAbpos and TPOAbpos were present in 71, 86 and 36% of the AAD patients, respectively. Furthermore, in order to evaluate the effect of HLA/21OH-Abs status on the production of TPO-Abs the patients were divided into four subgroups (Gr): Gr1: HLAhigh-R/21OH-Abneg; Gr 2: HLAhigh-R/21OH-Abpos; Gr 3:HLAlow-R/21OH-Abneg; Gr4:HLAlow-R/21OH-Abpos. While the Gr 2 and Gr 4 had significantly higher concentration of TPO-Abs in median (44.5 and 55 UI/ml) than Gr 3 (1.3 UI/ml; Pcorrected =7.4 × 10−4 and 7.4 × 10−3 respectively) no difference was observed compared to Gr 1. Also a significant correlation was found between 21OH-Abs and TPO-Abs titers (ρ=0.21, P=0.01).
Both the genetic background of AAD as detected by the HLA risk alleles DQ2/DQ8 and the status of the 21OH-Abs are associated with thyroid autoimmunity in APS-2. This combination may be an indicator of the enhanced risk of polyglandular destruction in autoimmune Addison’s disease.
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2024 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more